Physician profile
Mark Rotenstein
NPI 1992258008
$10,856.65
in general payments reported to CMS, 2019-2025
31 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,732 · 2021: $2,070 · 2022: $4,931 · 2023: $1,440 · 2024: $333 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403 · Travel and Lodging: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.46 |
| Travel and Lodging | $719.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,769.78 | 2022-2023 | |
| Impactortho, INC. | $2,333.07 | 2022 | |
| Micromed INC | $1,444.53 | 2020 | |
| Stryker Corporation | $1,048.73 | 2021-2023 | Prophecy |
| Paragon 28, INC. | $879.12 | 2021-2023 | Baby Gorilla |
| Medical Device Business Services, INC. | $534.98 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $387.36 | 2021 | |
| Treace Medical Concepts, INC. | $286.66 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $216.31 | 2023-2025 | Acthar |
| Acumed LLC | $161.00 | 2021 | |
| Depuy Synthes Sales INC. | $150.44 | 2023-2025 | Na, Motoband, Minibunion |
| Paratek Pharmaceuticals, INC. | $79.94 | 2024 | Nuzyra |
| Wright Medical Technology, INC. | $77.93 | 2020 | |
| Ucb, INC. | $64.47 | 2025 | Bimzelx |
| Octapharma USA, INC. | $49.06 | 2024 | Octagam Immune Globulin (Human) |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saxum Surgical, INC. | $40.01 | 2024 | |
| Kerecis Limited | $33.18 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $32.62 | 2023 | Puraply |
| Phadia US INC. | $31.02 | 2022-2023 | Immunocap |
| Exact Sciences Corporation | $29.67 | 2024 | Cologuard Collection Kit |
| Bioventus LLC | $25.57 | 2025 | Exogen Ultrasound Bone Healing System |
| Aurinia Pharma U.S., INC. | $24.58 | 2024 | Lupkynis |
| Amgen INC. | $21.72 | 2022 | |
| Merck Sharp & Dohme LLC | $21.23 | 2025 | Capvaxive, Gardasil 9 |
| Abbvie INC. | $20.83 | 2024 | |
| Novo Nordisk INC | $20.67 | 2022 | |
| Medtronic, INC. | $15.75 | 2024 | Accurian |
| Pacira Pharmaceuticals Incorporated | $14.67 | 2021 | |
| Electromed, INC. | $14.50 | 2022 | |
| Smith+Nephew, INC. | $14.16 | 2022 | |
| United Therapeutics Corporation | $13.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rotenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.